Macrogen Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
6,426
3,033
9,131
5,680
7,559
Depreciation, Depletion & Amortization
5,264
7,308
9,092
11,239
11,237
Other Funds
-
-
1,133
116
-
Funds from Operations
11,364
12,457
15,910
15,669
13,868
Changes in Working Capital
2,199
5,874
8,755
8,060
1,817
Net Operating Cash Flow
9,165
6,584
7,155
23,729
15,685
Capital Expenditures
2,995
22,426
9,782
14,881
11,632
Sale of Fixed Assets & Businesses
453
454
1,190
644
22,630
Purchase/Sale of Investments
828
16,883
877
3,475
8,117
Net Investing Cash Flow
1,614
38,855
7,746
14,879
3,011
Issuance/Reduction of Debt, Net
1,300
19,000
1,193
9,117
2,649
Net Financing Cash Flow
1,300
18,372
47
10,177
1,899
Net Change in Cash
8,665
13,952
512
19,238
16,571
Free Cash Flow
6,217
15,817
2,155
8,937
4,504
Net Assets from Acquisitions
-
-
-
3,322
-
Other Sources
100
-
-
520
130
Change in Capital Stock
-
628
2,279
944
750
Exchange Rate Effect
185
53
32
210
226
Other Uses
-
-
30
1,314
-

About Macrogen

View Profile
Address
10/F, World Meridian Venture Center
Seoul SL 08511
Korea, Republic Of
Employees -
Website http://www.macrogen.co.kr
Updated 09/14/2018
Macrogen, Inc. engages in the provision genetic research and biotechnology services. It services include genome sequencing, oligonucleotide, microarray, genetically engineered mouse, and clinical sequencing. The company was founded on June 5, 1997 and is headquartered in Seoul, South Korea.